Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Asher

Showing results (101-110 of 6,821) with videos related to

Pageof 683
Sort By:
Nature Reviews. Drug Discovery|February 2, 2018
EMA recommended 35 new drugs in 2017Asher Mullard
Nature Reviews. Drug Discovery|June 10, 2022
BMS buys Turning Point Therapeutics and its kinase inhibitors for $4.1 billionAsher Mullard
Nature Reviews. Drug Discovery|June 10, 2022
GSK buys Affinivax for up to $3.3 billion, bolstering its vaccine pipelineAsher Mullard
Nature|June 29, 2022
COVID antibody drugs have saved lives - so why aren't they more popular?Asher Mullard
Nature Reviews. Drug Discovery|May 27, 2021
First approval of a complement C3 inhibitor opens up autoimmune and inflammatory opportunitiesAsher Mullard
Nature Reviews. Drug Discovery|April 17, 2023
Setting GPCRs freeAsher Mullard
Nature Reviews. Drug Discovery|May 10, 2023
FDA approves second microbiome-based C. difficile therapyAsher Mullard
Nature Reviews. Drug Discovery|August 8, 2020
COVID-19 vaccine guidelinesAsher Mullard
Nature Reviews. Drug Discovery|July 9, 2020
COVID-19 platform trial deliversAsher Mullard
Nature Reviews. Drug Discovery|August 14, 2020
Pharmaceutical firms commit US$1 billion to antibiotic developmentAsher Mullard
Pageof 683

Showing results (101-110 of 6,821) with videos related to

Sort By:
Pageof 683
Nature Reviews. Drug Discovery|February 2, 2018
EMA recommended 35 new drugs in 2017Asher Mullard
Nature Reviews. Drug Discovery|June 10, 2022
BMS buys Turning Point Therapeutics and its kinase inhibitors for $4.1 billionAsher Mullard
Nature Reviews. Drug Discovery|June 10, 2022
GSK buys Affinivax for up to $3.3 billion, bolstering its vaccine pipelineAsher Mullard
Nature|June 29, 2022
COVID antibody drugs have saved lives - so why aren't they more popular?Asher Mullard
Nature Reviews. Drug Discovery|May 27, 2021
First approval of a complement C3 inhibitor opens up autoimmune and inflammatory opportunitiesAsher Mullard
Nature Reviews. Drug Discovery|April 17, 2023
Setting GPCRs freeAsher Mullard
Nature Reviews. Drug Discovery|May 10, 2023
FDA approves second microbiome-based C. difficile therapyAsher Mullard
Nature Reviews. Drug Discovery|August 8, 2020
COVID-19 vaccine guidelinesAsher Mullard
Nature Reviews. Drug Discovery|July 9, 2020
COVID-19 platform trial deliversAsher Mullard
Nature Reviews. Drug Discovery|August 14, 2020
Pharmaceutical firms commit US$1 billion to antibiotic developmentAsher Mullard
Pageof 683